新辅助/辅助化疗会改变经典浸润性小叶癌的自然病程吗？ - Suppr

Suppr

超能文献

Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?

作者信息

Katz Artur

出版信息

J Clin Oncol. 2005 Sep 20;23(27):6796; author reply 6796-7. doi: 10.1200/JCO.2005.02.1402.

DOI:10.1200/JCO.2005.02.1402

PMID:16170189

Abstract

摘要

相似文献

Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?

J Clin Oncol. 2005 Sep 20;23(27):6796; author reply 6796-7. doi: 10.1200/JCO.2005.02.1402.

Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.

Br J Surg. 2008 Apr;95(4):433-7. doi: 10.1002/bjs.6044.

[Response evaluation with mammography and ultrasound].

Zentralbl Gynakol. 1996;118(10):572-3.

Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.

Breast Cancer. 2008;15(2):133-40. doi: 10.1007/s12282-008-0030-7.

[Significance and specifics of surgical treatment in locally advanced breast cancer].

Vopr Onkol. 2011;57(5):578-83.

[Clinical and morphological features and treatment for lobular breast cancer].

Vopr Onkol. 2013;59(3):386-9.

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy.

Cancer. 2007 Oct 15;110(8):1687-96. doi: 10.1002/cncr.22981.

NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.

J Natl Compr Canc Netw. 2006 Mar;4 Suppl 1:S1-26.

Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?

Breast J. 2009 Mar-Apr;15(2):146-54. doi: 10.1111/j.1524-4741.2009.00689.x.

Management of locally advanced breast cancer. Mini-review.

Minerva Chir. 2007 Aug;62(4):249-55.

引用本文的文献

Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.

Breast Cancer Res Treat. 2023 Jul;200(2):217-224. doi: 10.1007/s10549-023-06959-3. Epub 2023 May 21.

Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the Breast.

Res Sq. 2023 Mar 20:rs.3.rs-2658909. doi: 10.21203/rs.3.rs-2658909/v1.

Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.

BMC Cancer. 2020 Feb 21;20(1):136. doi: 10.1186/s12885-020-6614-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?

作者信息

Katz Artur

出版信息

J Clin Oncol. 2005 Sep 20;23(27):6796; author reply 6796-7. doi: 10.1200/JCO.2005.02.1402.

DOI:10.1200/JCO.2005.02.1402

PMID:16170189

Abstract

摘要